Key Takeaways
- A firm that manages $3.82 billion sold its whole stakes in Lumentum, Western Digital and Core Scientific in the third quarter, its latest 13F shows.
- All three stocks are down at least 35% since Sept. 30. Intel fell just as hard, and the fund grew that stake more than fivefold while opening a new position in Microsoft.
- Lumentum’s price now follows Marvell’s stock under an all-stock buyout. Western Digital trades at about 10x forward earnings, and every analyst’s target is above its price.
- Core Scientific is the sale the numbers back best, and Western Digital is the one I’d buy back.
Avala Global, which manages $3.82 billion, has sold out of three stocks it held in June. Its 13F for the quarter ended Sept. 30, filed Nov. 16, shows no shares left in Lumentum (LITE), Western Digital (WDC) or Core Scientific (CORZ). They were three of the nine sizable positions it sold out of completely.
It didn’t give up on tech, though. It opened a stake in Microsoft (MSFT) and more than quintupled its Intel (INTC) shares. A 13F only shows what a fund held on the last day of the quarter, so there’s no telling when it sold or at what price.
TIKR tracks 25 analysts on Lumentum. How many say “Buy”?
See the full breakdown of Buy, Hold, and Sell ratings on Lumentum, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Lumentum’s Analyst Ratings
Lumentum is a bet on Marvell now
At June 30, the fund held 182,037 Lumentum shares worth $156 million, 5.8% of its 13F stocks. The stock is down 35% since Sept. 30, even though CEO Michael Hurlston told CNBC this month that “our demand couldn’t be stronger.”
Much of the drop came after Marvell’s all-stock offer. Marvell is offering 4.5 of its shares for each Lumentum share, which was worth about $1,132 a share when the deal was announced, and Lumentum fell 25% in two days after the news. Since then, Lumentum’s price has followed Marvell’s. Bernstein cut its target to $635 from $900 on Nov. 9, then raised it to $700 a day later, both times to reflect Marvell’s share price.
That makes analysts’ targets a poor guide while the deal is pending. Buying Lumentum today mostly means buying Marvell at 4.5 to 1, plus the risk that the deal breaks. The companies are aiming to close in the first half of 2028, and analysts expect China’s antitrust review alone to take 12 to 18 months. If regulators block the deal, Marvell owes Lumentum a $3.2 billion fee.
Western Digital got cheap fast
The fund held 189,100 Western Digital shares worth $121 million at June 30, 4.5% of its 13F stocks. The stock is down 56% since Sept. 30 and 65% below its 52-week high. Some of the selling came on news from other parts of the storage market: it fell nearly 8% on a flash maker’s cautious outlook, even though Western Digital sells hard drives.
Analysts haven’t followed the stock down. Their average target has only slipped a little from its October peak:

The average from 26 analysts is $613.38, down from a high of $673.50 on Oct. 7. Even the lowest target, $405, is well above the $283.33 close. At about 10x forward earnings, the market is pricing in a much bigger fall in earnings than analysts expect.
Core Scientific’s targets keep slipping
The fund held 3.98 million Core Scientific shares worth $102 million at June 30, 3.8% of its 13F stocks. The stock is down 47% since Sept. 30, even though CoreWeave’s blowout quarter is good news for Core Scientific’s $10 billion contract.
Unlike Western Digital’s average target, Core Scientific’s has been falling since the summer:

It peaked at $37.12 on Aug. 3 and was $27.24 on Nov. 11, from 22 analysts, about where it stood a year ago. The stock still trades at about 42x forward earnings, so it’s priced for plenty of growth even as the Street lowers what it thinks the shares are worth.
The stock it added fell just as hard
Before giving the fund too much credit, look at what it bought. It ended September with 1.46 million Intel shares worth $176 million, 5.8% of its 13F stocks and its sixth-largest position, after adding 431% to its share count from June. Intel is down 54% since Sept. 30, about as much as Western Digital, after a $1.6 billion guidance miss. Consensus 2027 normalized EPS has fallen to $1.79 from $2.11 before the third-quarter report, and the stock still trades at about 40x forward earnings.
Microsoft has held up much better. The fund’s new stake, 400,773 shares worth $206 million, is 6.7% of its 13F stocks and its third-largest position. The stock is down 1% since Sept. 30 and trades at about 24x forward earnings, close to its 12-year average of 25.9x.
The one I’d buy back
Of the three sales, Core Scientific’s is the one the numbers back best: about 42x forward earnings, with the average target falling since August. Lumentum is a bet on Marvell’s stock and on regulators until 2028. Western Digital is the one I’d want back. At about 10x forward earnings, with every analyst’s target above the price, a lot of bad news is already in the stock.
The risk is that the estimates behind that 10x fall sharply, the way Intel’s did after its last report. Western Digital’s next report, expected early next year, will show whether analysts cut. The fund’s next 13F, due in mid-February, will show whether it bought any shares back.
So what is Lumentum stock actually worth?
TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Lumentum could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!